Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01678937 · ClinicalTrials.gov registry record

Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents

A clinical trial of Immunosuppression and Liver Transplant Rejection, sponsored by Northwestern University.

Completed
Registry status
31
Enrollment target
1
Study location

NCT01678937 is a study of Immunosuppression and Liver Transplant Rejection that has completed, run by Northwestern University. The registered enrollment target is 31 participants, below the 645-participant average among 12 other Immunosuppression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01678937, a study of Immunosuppression and Liver Transplant Rejection, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
31 participants
Enrollment target
1
Study location

Study Summary

This study is being done with the purpose of trying to understand if and why transplant recipients may develop tolerance to their transplanted organ. Tolerance means being able to lower or take away immunosuppression (anti-rejection medications) without causing organ rejection.

Conditions Studied

Immunosuppression Liver Transplant Rejection

Interventions

  • PROCEDURE Blood Draw - Rapamycin
  • PROCEDURE Blood Draw from Control Subjects
  • PROCEDURE Blood Draw - CyA
  • PROCEDURE Blood Draw - Tacrolimus
  • PROCEDURE Blood Draw - MMF

Study Locations (1)

Illinois

  • Northwestern Memorial Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2007-09
Est. Completion 2008-09

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01678937

The ClinicalTrials.gov registry entry for NCT01678937 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 645-participant average among 12 other Immunosuppression trials with a reported enrollment target (95% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Immunosuppression appearing as the primary indexed condition, and to 5 interventions - of which Blood Draw - Rapamycin is the first listed.

NCT01678937 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01678937 about?

NCT01678937 is a clinical study titled "Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents". This study is being done with the purpose of trying to understand if and why transplant recipients may develop tolerance to their transplanted organ. Tolerance means being able to lower or take away immunosuppression (anti-rejection medications) without causing organ rejection.

What is the current status of trial NCT01678937?

This trial is currently completed. The enrollment target is 31 participants. The study started on 2007-09. Estimated completion is 2008-09.

What conditions does trial NCT01678937 study?

This clinical trial studies the following conditions: Immunosuppression, Liver Transplant Rejection.

What interventions are being tested in trial NCT01678937?

The interventions under investigation include: Blood Draw - Rapamycin (PROCEDURE), Blood Draw from Control Subjects (PROCEDURE), Blood Draw - CyA (PROCEDURE), Blood Draw - Tacrolimus (PROCEDURE), Blood Draw - MMF (PROCEDURE).

Who is sponsoring clinical trial NCT01678937?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01678937 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Immunosuppression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Immunosuppression

All registered trials for this condition

Liver Transplant Rejection

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.